Physician profile
David John
NPI 1811226970
$432.63
in general payments reported to CMS, 2019-2025
8 companies · $16.03 in 2025
The $16.03 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.95 · 2022: $206 · 2023: $60.10 · 2024: $133 · 2025: $16.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $209.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $181.35 | 2022 | |
| Merck Sharp & Dohme LLC | $62.39 | 2023-2024 | Welireg, Keytruda, Lynparza |
| Exelixis INC. | $51.14 | 2024-2025 | Cabometyx |
| Bayer Healthcare Pharmaceuticals INC. | $37.65 | 2024 | |
| Janssen Biotech, INC. | $29.63 | 2023 | Erleada |
| Sun Pharmaceutical Industries INC. | $28.41 | 2024 | |
| Convatec INC. | $25.11 | 2022 | |
| Neurocrine Biosciences, INC. | $16.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David John listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.